David S. Kabakoff is an entrepreneur and businessperson who founded Strategy Advisors LLC, Salmedix, Inc. and Amplimmune, Inc. and who has been at the helm of 9 different companies. Dr. Kabakoff occupies the position of Chairman of NextCure, Inc., Partner at Healthquest Capital Management Co LLC, Executive Partner & Private Equity at Sofinnova Investments, Inc. and Chairman at Lineagen, Inc.
He is also on the board of 9 other companies.
In his past career he was Non-Executive Chairman for Cebix, Inc., President & Chief Executive Officer at Strategy Advisors LLC, Chairman & Chief Executive Officer for Corvas International, Inc., Chairman & Chief Executive Officer for Salmedix, Inc., Chairman at Amplimmune, Inc., Chairman at Trius Therapeutics, Inc., President & Chief Executive Officer for Spiros Development Corp II, Inc., Executive Vice President of Dura Pharmaceuticals, Inc., Senior Executive Officer at Hybritech, Inc. and Director at Jewish Community Foundation of San Diego.
He received an undergraduate degree from Case Western Reserve University and a doctorate from Yale University.